CDC advisory panel recommends Pfizer boosters for older, some high-risk Americans

Pfizer vaccine doses.
(Image credit: Luis Acosta/AFP via Getty Images)

Advisors to the Centers for Disease Control and Prevention voted unanimously on Thursday to recommend booster doses of Pfizer's COVID-19 vaccine for Americans 65 and older, residents of long-term care facilities, and people between 50 and 64 with underlying health conditions.

On Wednesday, the Food and Drug Administration authorized boosters for people 65 and older, frontline workers, and individuals with underlying conditions that put them at high risk of getting severe COVID if infected.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Catherine Garcia, The Week US

Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.